Vol 81, No 4 (2023)
Clinical vignette
Published online: 2023-03-04

open access

Page views 2081
Article views/downloads 341
Get Citation

Connect on Social Media

Connect on Social Media

Early-onset atherosclerosis in a patient with Tangier disease: Not all that is gold glitters

Gualter Silva1, Mariana Brandão1, Mariana Rocha2, Wilson Ferreira1, Marisa Silva1, Ricardo Fontes-Carvalho13
Pubmed: 36871306
Kardiol Pol 2023;81(4):419-420.

Abstract

Not available

Clinical vignette

Early-onset atherosclerosis in a patient with Tangier disease: Not all that is gold glitters

Gualter Silva1Mariana Brandão1Mariana Rocha2Wilson Ferreira1Marisa Silva1Ricardo Fontes-Carvalho13
1Department of Cardiology, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
2Department of Neurology, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
3Cardiovascular R&D Center — UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal

Correspondence to:

Gualter Silva, MD.

Centro Hospitalar Vila Nova de Gaia/Espinho,

Rua Conceição Fernandes S/N, 4434-502, Vila Nova de Gaia, Portugal,

phone: +35 1 918 347 142,

e-mail: gualterssilva@gmail.com

Copyright by the Author(s), 2023

DOI: 10.33963/KP.a2023.0061

Received: December 28, 2022

Accepted: February 11, 2023

Early publication date: March 5, 2023

A 43-year-old woman with a previous history of smoking and hypertension was referred for cardiology consultation for recent-onset fatigue and dyspnea. She also reported upper limb joint pain and paresthesia. She denied a family history of cardiovascular disease.

Upon examination, the patient presented with periorbital xanthomas and significant blood pressure differential between the upper and lower limbs. A comprehensive neurologic examination showed motor deficits in the left hand and left facial paresis. Serum levels of total cholesterol and triglycerides were 99 and 105 mg/dl, respectively, and high-density lipoprotein (HDL) cholesterol was undetectable (<3 mg/dl). Other laboratory tests were unremarkable.

The initial transthoracic echocardiogram showed moderate aortic regurgitation with normal biventricular size and function. Compu- ted tomography angiography showed complex atherosclerosis throughout the entire thoracic and abdominal aorta and their branches (Figure 1A; Supplementary material, Figure S1, Video S1).

Figure 1. A. Computed tomography angiography showing massive calcification of the ascending thoracic aorta. B. Coronary angiography with diffuse and significant stenosis in the proximal/mid left anterior descending artery. CE. Transesophageal echocardiogram showing calcified descending aorta (C) and aortic valve (D) and severe aortic regurgitation (E). F. Aortography showing TAVI in a patient with Tangier disease
Abbreviation: TAVI, transcatheter aortic valve implantation

Due to onset of exertional chest pain, invasive coronary angiography was performed which showed diffuse three-vessel coronary artery disease (CAD) (Figure 1B). Cardiac magnetic resonance demonstrated an unspecific focus of intramural fibrosis in the mid-segment of the anterior wall and extensive perfusion defect in all coronary territories, mainly in those irrigated by the left anterior descending artery (LAD) and right coronary artery.

The case was discussed by a multidisciplinary Heart Team, and a surgical approach was deemed impracticable due to porcelain aorta. Percutaneous coronary intervention on the LAD lesion was successfully performed. A conservative approach was adopted for other lesions.

Considering the cardiovascular and neurological findings, unmeasurable HDL cholesterol value, and extensive and diffuse accelerated atherosclerosis, the diagnosis of Tangier’s disease was suspected, even without the hallmark sign of orange-colored tonsils. Genetic testing was performed and two heterozygous variants in the ABCA1 gene c.1834G>Tp(Glu612*) and c.4297G>Tp(Glu1433*) were detected, confirming the diagnosis.

After a few months of clinical improvement, the patient showed symptomatic deterioration, with recurrent fatigue that significantly impacted her daily activities. A transesophageal echocardiogram was performed, which showed a tricuspid calcified aortic valve and worsened aortic regurgitation, now classified as severe (Figure 1CE, Supplementary material, Video S2). Additionally, mild dilatation of the left ventricle was observed.

Percutaneous aortic valve implantation was deemed the only viable approach, and a 23 mm Edwards Sapien 3 Ultra valve was implanted, with no procedural complications (Figure 1F). During follow-up, the patient exhibited a significant clinical improvement.

Tangier disease is a rare genetic disorder characterized by extremely low levels of HDL cholesterol, with fewer than 150 cases reported worldwide. This results in cholesterol accumulation in various tissues, leading to an early onset of atherosclerosis and peripheral neuropathy [1, 2]. As no specific curative treatment is currently available, early identification of these patients and management of other risk factors such as low-density lipoprotein cholesterol levels, hypertension, diabetes, and smoking are crucial. A lipid profile and molecular genetic testing are recommended in relatives.

We report a well-documented case of a young female diagnosed with Tangier disease, who presented with accelerated atherosclerosis in multiple arteries and required several challenging targeted interventions. In this case, an integrative and multidisciplinary approach was key to unveiling a rare diagnosis in a setting where some of the classic findings (such as the bright orange tonsils, hepatosplenomegaly, and corneal opacity) were missing showing that not all that is gold glitters!

Supplementary material

Supplementary material is available at https://journals.viamedica.pl/kardiologia_polska.

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at kardiologiapolska@ptkardio.pl.

REFERENCES

  1. Muratsu J, Koseki M, Masuda D, et al. Accelerated Atherogenicity in Tangier Disease. J Atheroscler Thromb. 2018; 25(10): 10761085, doi: 10.5551/jat.43257, indexed in Pubmed: 29563393.
  2. Koseki M, Yamashita S, Ogura M, et al. Current Diagnosis and Management of Tangier Disease. J Atheroscler Thromb. 2021; 28(8): 802810, doi: 10.5551/jat.RV17053, indexed in Pubmed: 33994407.



Polish Heart Journal (Kardiologia Polska)